Mitoxantrone for MS linked to colorectal cancer risk

Treatment with mitoxantrone for multiple sclerosis carries only a mildly increased risk of malignancy overall, but the risk of colorectal cancer and leukaemia is heightened, researchers have found.
Source: MedWire News - Category: Consumer Health News Tags: Multiple sclerosis Source Type: news